Mathematical and Experimental Validation of an Approach for Simultaneously Determining the Binding Parameters of Two Drugs to a Receptor.

Sai Qiao,Yuanyuan Ou,Lun Liu,Siwang Wang,Liujiao Bian,Xinfeng Zhao
DOI: https://doi.org/10.1016/j.chroma.2022.463593
2022-01-01
Abstract:Quantifying drug-protein interactions has a pivotal role in both early phase drug development and clin-ical processes. Diverse affinity chromatographic methods like nonlinear chromatography can realize such quantification, however, their throughputs are challenged due to the loading of a single ligand during each run. This work derivatized a new equation for simultaneously determining the bindings of two lig-ands to a protein relying on assumption that the retention factors of the ligands are dependent on their injection amounts. Experimental validation of the derivatization was performed on an immobilized en-dothelin A receptor (ETAR) column taking ambrisentan, bosentan, and macitentan as injecting solutes. All three ligands presented a decrease in retention times along with increasing moles of injection when they were singly injected into the column. Likewise, negative relationships between the retentions and the injection amounts were observed when co-injection of ambrisentan/bosentan or bosentan/macitentan was performed, thus confirming the assumption of the derivatization. The association constants of am-brisentan, bosentan, and macitentan binding to ETAR were (1.42 +/- 0.78) x10 4 , (1.81 +/- 0.22) x10 4 , and (1.71 +/- 0.41) x10 4 L/mol when each of them was singly loaded on the column. Such data displayed in-significant changes in four weeks thereby providing a proof of good stability of the column during the period. Co-injections of the two ligand pairs resulted in the association constants of (2.97 +/- 0.13) x10 4 for ambrisentan, (2.51 +/- 0.87) x10 4 for bosentan, and (2.88 +/- 0.34) x10 4 L/mol for macitentan. These re-sults were in good agreement with the calculation when each of the ligands was injected alone into the column and demonstrated little differences from the data by nonlinear chromatography. Owning to the simultaneous analysis of two ligands, the throughput of the proposed method was twofold higher than the typical assays including frontal analysis, zonal elution, and nonlinear chromatography. It is possible to become an alternative for rapid analysis of drug-protein interaction.(c) 2022 Elsevier B.V. All rights reserved.
What problem does this paper attempt to address?